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ABSTRACT 
 
Synergistic Interactions between Uteroferrin and Secreted Phosphoprotein 1 in Hematopoietic 
Niches. (May 2014) 
 
Lauren Michelle Ehle 
Department of Biomedical Sciences 
Texas A&M University 
 
Research Advisor: Dr. Fuller W. Bazer 
Department of Animal Science 
  
  
Synthesis of red blood cells is vital to maintaining health in organisms; however, current 
therapeutic procedures to correct inadequate levels of erythropoiesis for production of red blood 
cells are not sufficient to improve the situation effectively. For this reason, further research is 
needed in order to implement new therapeutic methods to ameliorate conditions such as anemia. 
Uteroferrin [aka UF, phosphatase, acid, type 5, tartrate-resistant (ACP5) and tartrate-resistant 
acid phosphatase (TRAP)] and secreted phosphoprotein 1 (SPP1) are proteins that are proposed 
to co-localize in sites of erythropoiesis which are referred to as hematopoietic niches.  The 
placental yolk sack, as well as liver, spleen, and bone of fetal mice are the major hematopoietic 
centers during fetal development.  Therefore, this research was to obtain those fetal tissues at 
different stages of gestation and perform immunohistochemistry, in situ hybridization analysis, 
western blotting, and biological assays to determine co-localization of UF and SPP1.  
Subsequent research will be to gain further insight into the roles of UF and SPP1 and their 
possible synergistic interactions with respect to stimulation of erythropoiesis. 
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NOMENCLATURE 
  
 
  
 UF   Uteroferrin 
ACP5   Phosphatase, Acid Type 5, Tartrate-Resistant  
TRAP   Tartrate-Resistant Acid Phosphatase  
SPP1   Secreted Phosphoprotein 1 
LAP   Lysomal Acid Phosphatase 
HSPC   Hematopoietic Stem and Progenitor Cells 
GE   Glandular Epithelium  
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CHAPTER I 
 
INTRODUCTION 
 
 
  
Problems in current treatments for anemia 
Erythropoiesis is the process by which hematopoietic stem and progenitor cells (HSPC) 
differentiate into erythrocytes or red blood cells. A decreased concentration of O2 in blood is 
detected by the kidneys, which in turn secrete erythropoietin to stimulate erythropoiesis and 
production of red blood cells. Erythrocytes are crucial to sustaining life in all vertebrate 
organisms, and are essential in all stages of life: embryonic, fetal, neonatal, adolescent, and adult 
[1].  When the organism is not experiencing proper red blood cell formation, severe health 
consequences are likely to arise. One of the possible consequences is anemia. Anemia is a 
disorder in which the level of healthy, thriving red blood cells in the body is lower than required 
to carry the appropriate amount of oxygen to all cells in the body. One of the most prevalent 
forms of anemia involves iron deficiency. A crucial protein inside a red blood cell is known as 
hemoglobin. Hemoglobin is rich in iron and is the part of the RBC that binds oxygen and enables 
them to carry oxygen to the rest of the body. Multi-organ, such as brain, heart, and kidney, 
injuries present increased risk factors for patients suffering from acute and chronic anemia. To 
make matters worse, current treatments for anemia such as transfusions, erythropoiesis 
stimulating agents, and blood substitutes have not been proven to improve health of the patient 
sufficiently. This highlights the demand to develop new therapeutics to stimulate erythropoiesis 
[2]. The findings obtained from the proposed research will lay a foundation for formulating new 
therapeutic approaches for treating anemia that will compliment or replace transfusions and use 
of blood substitutes.  
6	  
	  
UF is a progesterone-induced protein secreted by uterine glandular epithelium (GE) of pigs and 
other ungulates, as well as human placenta, spleen and osteoclasts [3].  In previous 
investigations, UF-lysomal acid phosphatase (LAP) double knockout mice were produced and 
found to have severe skeletal defects [4].  So it is clear that this protein is crucial to bone 
development.  However, these researchers did not investigate its effects on erythropoiesis, which 
occurs in flexible tissue known as bone marrow in the interior of certain bones. More recent 
results indicate that mutations in UF reduce or eliminate acid phosphatase activity which 
increases the presence of hyperphosphorylated SPP1 associated with skeletal defects, 
neurological problems, developmental delays, increased production of interferon alpha that leads 
to systemic autoimmunity and impaired erythropoiesis [5]. Based on preliminary results from Dr. 
Bazer’s laboratory, it is proposed that UF, due to its acid phosphatase activity, interacts with 
SPP1 to reduce its state of phosphorylation and thereby increase the bioactivity of SPP1 within 
the hematopoietic niche to stimulate hematopoiesis/erythropoiesis [5].  Specifically, this  
research tested the hypothesis that UF co-localizes with SPP1 in both fetal and adult 
“erythropoietic niches” to stimulate erythropoiesis.     
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CHAPTER II 
METHODS 
 
 
  
Research to test the hypothesis was conducted in a laboratory setting in which required 
techniques are established and published [7].  Utilizing the advanced equipment and methods 
provided in the laboratory of the faculty advisor, Dr. Fuller Bazer, I determined temporal and 
spatial (cell-specific) changes in co-localization of UF and SPP1 in yolk sac, liver, spleen and 
bone of fetuses from mice in which the major hematopoietic niches are located. The primary 
technique performed on the mouse tissue is known as immunohistochemistry. 
Immunohistochemistry is a technique that identifies specific targeted proteins in tissues. The 
tissue is treated with specific antibodies that bind to the protein of interest.  The antibody binds 
to the molecule under study and subsequently, when treated with a color reaction molecule, 
forms a visual precipitate that can be viewed under a microscope. Immunohistochemistry can be 
used to aid in disease diagnosis, detect the presence of microorganisms, and, in basic research, to 
understand how cells grow and become specialized [8].  In this study, immunohistochemistry 
was used to determine the co-localization of UF and SPP1 proteins in liver, bone, placenta, and 
yolk sac of fetal tissues from mice. Further experiments will shine more light on the results and 
confirm the synergistic effects in greater detail. In situ hybridization will determine temporal and 
cell-specific changes in expression of UF and SPP1 mRNAs in hematopoietic centers of the 
mouse conceptus during gestation. In addition, western blotting will confirm the presence of UF 
and SPP1 in tissues of interest.  
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CHAPTER III 
RESULTS 
 
 
  
After successful immunohistochemical reactions were conducted on liver, bone, placenta, and 
yolk sac of fetal tissues from mice, results were analyzed to determine if our hypothesis was 
indeed valid. The specific 
tissue staining detected both 
UF and SPP1 proteins in 
hematopoietic niches 
including allantois, bone 
marrow, and yolk sac (Figure 
1).  This indicates that UF and 
SPP1 are in fact co-localized 
with the potential to interact 
and play a dual role in 
mediating molecular and 
biochemical reactions in these 
tissues  that likely affect 
hematopoiesis and, in 
particular, erythropoiesis. 
Confirmed co-localization of 
SPP1 and UF was established 
for yolk sac, bone marrow, and allantois of the placenta of fetal mice. As shown in Figure 1, the 
Figure	  1.	  Immunohisotchemistry	  demonstrating	  co-­‐localization	  
of	  UF	  and	  SPP1	  proteins	  in	  fetal-­‐placental	  tissues	  from	  mice:	  A.	  
allantois	  SPP1;	  B	  allantois	  UF;	  C	  bone	  marrow	  SPP1;	  D	  bone	  
marrow	  UF;	  E	  yolk	  sac	  SPP1	  and	  F	  yolk	  sac	  UF	  	  
A	   B	  
C	   D	  
E	   F	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specific proteins were successfully detected (brown precipitate) and determined to co-localize in 
common niches. In addition, it was previously determined that there is co-localization of UF and 
SPP1 in erythroid islands of pig liver. The mechanism that we are proposing leads to synergistic 
effects on erythropoiesis based on co-localization of the two proteins and involves actions of UF 
to decrease the amount of phosphorylation of SPP1 which increase its biological activity. As 
mentioned previously, UF decreases phosphorylation of SPP1 to allow the bioactivity of SPP1 to 
have a more stimulatory effect. The action of SPP1 is to control the number of hematopoietic 
progenitor cells that move into the various differentiated states, such as erythrocytes. After 
erythropoiesis starts, UF stimulates hemoglobin synthesis and differentiation of erthyroid cells to 
mature red blood cells, rather than differentiating into megakaryocytes that would form platelets. 
UF up-regulates genes for the transcription factors that direct the pathway of differentiation of 
the erythroid progenitor cells toward formation of mature red blood cells which represents part of 
the synergy between UF and SPP1 to enhance erythropoiesis.  
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CHAPTER IV 
CONCLUSION 
 
 
  
The culmination of this research ended in the successful determination that UF and SPP1 are in 
fact co-localized in fetal-placental tissues of mice such as the allantoic membrane and yolk sac of 
the placenta, as well as bone marrow. The presence of UF and SPP1 is common to these niches 
which gives rise to their potential to interact and play a dual role in mediating molecular and 
biochemical reactions in the organism which is likely stimulatory to erythropoiesis. The 
mechanism that we are proposing to result in increased erythropoiesis is based on the acid 
phosphatase activity of UF which cleaves phosphate groups from SPP1 and subsequently 
increases its bioactivity and diminishes the presence of hyperphosphorylated SPP1 which is 
associated with severe skeletal defects and impaired erythropoiesis in an organism. Further 
experiments are required to solidify the results and allow advancement in potential strategies for 
treatments to improve erythropoiesis. In situ hybridization will determine temporal and cell-
specific changes in expression of UF and SPP1 mRNAs in hematopoietic centers of the mouse 
conceptus (embryo/fetus and placenta) during gestation. In addition, western blotting will 
confirm the presence of UF and SPP1 in tissues of interest. 
Impact on Treatments 
The goal of this research was to provide new knowledge to inform translational research for 
development of therapeutic approaches to increase erythropoiesis and reduce morbidity and 
mortality associated with anemia. These two proteins, UF and SPP1, exist in all species; 
therefore, the association between SPP1 and UF is not novel or unique to the mouse, and results 
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can be transferred in development of new strategies to enhance erythropoiesis in humans and 
animals. As a result, our findings are highly relevant to further narrow the research to be done 
toward developing new therapeutic approaches to mitigate human anemia through 
complimenting or replacing transfusions and use of blood substitutes.  
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